Cassava Sciences (NASDAQ:SAVA) stock illustrates the promise — and hazards — in biotechnology investing. Casssava management says it has a drug that can effectively treat Alzheimer’s Disease, one of the most destructive diseases known to man. They may have it, or they may not. It’s impossible for a small investor like me to know for
Stock Market
January wasn’t a good month for Coupang (NYSE:CPNG). As a result, the South Korean e-commerce company lost 29% of its value. CPNG stock has fared slightly better through the first week of February, but it has still been an up-and-down experience for shareholders. Source: Michael Vi / Shutterstock.com On Jan. 24, Coupang’s share price hit
It seems that investors’ concerns are beginning to ease around Alibaba (NYSE:BABA) stock. After the long, tumultuous downturn it appears that pressure is beginning to abate. Source: Kevin Chen Photography / Shutterstock.com That’s very good news for the Chinese tech giant that was among the worst suffering as a regulatory crackdown simmered along. That regulatory
Typically, when a publicly traded company loses nearly 16% of market value over the trailing month, there’s a reason for it — and usually not a good one. That’s the situation with SoFi Technologies (NASDAQ:SOFI). Though backed by several relevant innovations like fintech and cryptocurrencies, investors currently have a dim view of SOFI stock. Source:
Next week offers fourth-quarter earnings reports from a number of blue-chip companies and household names. In recent weeks, we have gotten mixed earnings reports from big banks and technology companies. While some companies, such as Wells Fargo (NYSE:WFC) and Alphabet (NASDAQ:GOOGL) blew the doors of their Q4 prints, other companies such as JPMorgan Chase (NYSE:JPM)
Like so many special purpose acquisition companies (SPACs), SoFi Technologies (NASDAQ:SOFI) stock has been a volatile one. Shares initially popped to $25 as excitement grew for the well-known FinTech firm. Source: rafapress / Shutterstock.com This also came during a time when entrepreneur Chamath Palihapitiya was on a massive winning streak with his SPAC deals. So in
Like other speculative growth stocks, Skillz (NYSE:SKLZ) continues to struggle. The days of “growth at any price” have long since passed. With the Federal Reserve raising rates, SKLZ stock continues to head lower. Source: Dennis Diatel / Shutterstock.com While it’s much cheaper now (it once traded for prices more than ten times what it trades for
Fisker (NYSE:FSR) plans to start producing its Ocean SUV model this year, which should prove to be positive news for the electric vehicle maker. However, a few key challenges remain and FSR stock has dropped more than 30% so far in 2022. This has many wondering if Fisker is still a hot play on electric
Although most folks love to parrot the phrase, “electric vehicles are the future,” that future may be further off than many think. Sure, we’d love to go green and all, but we also need to pay the bills. That’s where QuantumScape (NYSE:QS) could potentially provide the paradigm-shifting solution, explaining early sentiment for QS stock. Source:
The Nasdaq’s steep correction in the last month is punitive to the most speculative stocks in the last two years. This resulted in Skillz (NYSE:SKLZ) being stuck in a sustained downtrend. Investors are no longer willing to wait for an electronic gaming and multimedia firm to pivot to the sports betting market. SKLZ stock is
Investors in QuantumScape (NYSE:QS) haven’t had much to cheer since the electric vehicle battery maker went public via a merger with special-purpose acquisition company Kensington Capital Acquisition in November 2020. On its first day of trading, QS stock soared nearly 50%. Less than a month later, shares hit a high of $132.73, 465% above where
Lucid (NASDAQ:LCID) and LCID stock are facing very difficult challenges over both the short-term and the long-term. Unfortunately fans of LCID stock, there are much better stocks to buy in the electric-vehicle space. Source: Around the World Photos / Shutterstock.com Lucid’s Short-Term Challenges LCID stock has generally underperformed the EV sector since it underwent a
Will the real Rivian (NASDAQ:RIVN) please stand up? Six days after going public, RIVN stock charged to a closing price of $172.01. That was 128% above its initial public offering (IPO) price of $78. But as of this writing, the stock can be had for 17% below its IPO price. Source: James Yarbrough / Shutterstock.com
Down 30% year-to-date, space tourism company Virgin Galactic’s (NYSE:SPCE) stock looks like its grounded. Source: Brian Friedman / Shutterstock.com SPCE stock is now trading at $9.40 a share, down about 70% in the last six months and 85% below its 52-week high of $62.80. What was once a promising stock has crashed and burned, and
SoFi Technologies (NASDAQ:SOFI) is really shaking things up in 2022, which can only be good for beleaguered SOFI stock. Source: rafapress / Shutterstock.com In mid-January, the company announced it finally got approval from the Office of the Comptroller of the Currency and the Federal Reserve to operate a bank subsidiary, which will be called SoFi
In today’s market, fashions change quickly, as owners of PaySafe (NYSE:PSFE) stock know only too well. Source: Devina Saputri / Shutterstock.com Before it came public through a special purpose acquisition company (SPAC) deal worth $9 billion last March, our Mark Hake thought PaySafe stock was a sure thing. It opened for trade on Jan. 31
In recent days, volatility in electric vehicle (EV) stocks has ratcheted up once again. Established and early-stage names alike have sold off. Fisker (NYSE:FSR) is no exception. Already moving lower, this latest, much sharper drop has pushed FSR stock back to around $11 per share. Source: T. Schneider / Shutterstock.com Now, this isn’t the first time
If you bought Novavax (NASDAQ:NVAX) stock two years ago, before the Covid-19 pandemic, your investment has scored a 857% gain. Source: vovidzha / Shutterstock.com If you bought it on Dec. 17, you’re down 58%. Novavax should get approval on its Covid-19 vaccine, now called Nuxavoid, in 10 countries over the next few months. It will
As a media and telecom conglomerate, AT&T (NYSE:T) has many moving parts. But when it comes to T stock, there’s one thing that’s been top of mind among investors. That would be the future of its dividend. Source: Lester Balajadia / Shutterstock.com At today’s prices, it has a forward dividend yield of 8.58%. In today’s
In late summer 2021, DraftKings (NASDAQ:DKNG) rebounded to more than $60 and looked ready to find a new high. At its bullish peak, speculators bet that the National Football League (NFL) season start would lift DKNG stock. Traders also thought sports betting gaming license wins would be positive catalysts. Source: Tada Images / Shutterstock.com However,
- « Previous Page
- 1
- …
- 61
- 62
- 63
- 64
- 65
- …
- 85
- Next Page »